PTC Therapeutics | PTCT - Ebitda

Stock Price
70.97
Daily Change
0.47 0.67%
Monthly
-6.90%
Yearly
41.88%
Q1 Forecast
68.47

PTC Therapeutics reported $20.63M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Amgen USD 5.14B 775M Dec/2025
Biogen USD 573.2M 253.7M Dec/2025
BioMarin Pharmaceutical USD -5.26M 300.71M Sep/2025
Cytokinetics USD -277.18M 169.36M Sep/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Gilead Sciences USD 4.03B 628M Sep/2025
Incyte USD 414.5M 92.42M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Novartis USD 5.88B 290M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
TG Therapeutics USD 37.7M 25.41M Jun/2025
Ultragenyx Pharmaceutical USD -156.79M 65.44M Sep/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025
Xencor USD -30.52M 6.39M Jun/2025